Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Therapeutic Drug Monitoring
|
January 8, 1998
Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity
K Hedenmalm, M Sundgren, K Granberg, et al.
Neuropsychobiology
|
November 24, 1999
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults
J Sigurdh, O Spigset, P Allard, et al.
Maturitas
|
January 13, 2006
Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone
L Andréen, O Spigset, A Andersson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 8, 2018
Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry
S Hegstad, H Havnen, A Helland, et al.
European Journal of Clinical Pharmacology
|
January 17, 2002
The major fluvoxamine metabolite in urine is formed by CYP2D6
O Spigset, S Axelsson, A Norström, et al.
European Journal of Clinical Pharmacology
|
May 21, 1999
Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics
I Sundström, O Spigset, A Andersson, et al.
Acta Anaesthesiologica Scandinavica
|
July 16, 2015
Alfentanil during rapid sequence induction with thiopental 4 mg/kg and rocuronium 0.6 mg/kg: tracheal intubation conditions
M H Abou-Arab, J R Feiner, O Spigset, et al.
The Journal of Clinical Psychiatry
|
July 22, 1998
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
S Hägg, L Joelsson, T Mjörndal, et al.
Acta Psychiatrica Scandinavica
|
December 12, 1997
Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors
O Spigset, K Hedenmalm, M L Dahl, et al.
European Journal of Clinical Pharmacology
|
June 24, 1999
Absence of interaction between erythromycin and a single dose of clozapine
S Hägg, O Spigset, T Mjörndal, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Therapeutic Drug Monitoring
|
January 8, 1998
Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity
K Hedenmalm, M Sundgren, K Granberg, et al.
Neuropsychobiology
|
November 24, 1999
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults
J Sigurdh, O Spigset, P Allard, et al.
Maturitas
|
January 13, 2006
Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone
L Andréen, O Spigset, A Andersson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 8, 2018
Enantiomeric separation and quantification of R/S-amphetamine in urine by ultra-high performance supercritical fluid chromatography tandem mass spectrometry
S Hegstad, H Havnen, A Helland, et al.
European Journal of Clinical Pharmacology
|
January 17, 2002
The major fluvoxamine metabolite in urine is formed by CYP2D6
O Spigset, S Axelsson, A Norström, et al.
European Journal of Clinical Pharmacology
|
May 21, 1999
Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics
I Sundström, O Spigset, A Andersson, et al.
Acta Anaesthesiologica Scandinavica
|
July 16, 2015
Alfentanil during rapid sequence induction with thiopental 4 mg/kg and rocuronium 0.6 mg/kg: tracheal intubation conditions
M H Abou-Arab, J R Feiner, O Spigset, et al.
The Journal of Clinical Psychiatry
|
July 22, 1998
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
S Hägg, L Joelsson, T Mjörndal, et al.
Acta Psychiatrica Scandinavica
|
December 12, 1997
Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors
O Spigset, K Hedenmalm, M L Dahl, et al.
European Journal of Clinical Pharmacology
|
June 24, 1999
Absence of interaction between erythromycin and a single dose of clozapine
S Hägg, O Spigset, T Mjörndal, et al.
Page
of 13